Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010456772> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2010456772 endingPage "185" @default.
- W2010456772 startingPage "182" @default.
- W2010456772 abstract "Objective: To evaluate visual outcomes of eyes with choroidal neovascular membrane secondary to age-related macular degeneration that were initially treated with intravitreal ranibizumab then switched to intravitreal bevacizumab due to treatment failure. Design: Retrospective chart review. Participants: Fifty eyes of 50 patients presenting to the Barnes Retina Institute. Methods: Patients unresponsive to treatment with intravitreal ranibizumab were switched to intravitreal bevacizumab. Main outcome measures included number of intravitreal injections, visual acuity (VA), and resolution of leakage. Mean follow-up was 6 months after the final intravitreal bevacizumab injection. On average, each patient received 3.5 ranibizumab injections and 2.5 bevacizumab injections. Each patient received an average of 6 injections. Results: Resolution of leakage on fluorescein angiography and optical coherence tomography was achieved in 44 eyes (88%). Initial VA ranged from 20/30 to counting fingers (CF) (median VA 20/125). Final VA ranged from 20/20 to CF (median VA 20/100). Change in VA varied from loss of 2 lines to gain of 4 lines, but overall, remained stable (average gain 0.3 lines). Eighteen eyes (36%) had afinal VA of ≥ 20/50 and 18 eyes (36%) had a final VA of ≤ 20/200. Conclusions: Treatment with intravitreal bevacizumab may be effective, as measured by visual and anatomic criteria, in patients who are unresponsive to treatment with intravitreal ranibizumab." @default.
- W2010456772 created "2016-06-24" @default.
- W2010456772 creator A5010511809 @default.
- W2010456772 creator A5025007699 @default.
- W2010456772 creator A5044672309 @default.
- W2010456772 creator A5065539463 @default.
- W2010456772 date "2011-04-01" @default.
- W2010456772 modified "2023-10-09" @default.
- W2010456772 title "Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab" @default.
- W2010456772 cites W1975926216 @default.
- W2010456772 cites W2018777580 @default.
- W2010456772 cites W2023523208 @default.
- W2010456772 cites W2033245558 @default.
- W2010456772 cites W2042321005 @default.
- W2010456772 cites W2084101670 @default.
- W2010456772 cites W2085712747 @default.
- W2010456772 cites W2124415048 @default.
- W2010456772 doi "https://doi.org/10.3129/i10-095" @default.
- W2010456772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21708088" @default.
- W2010456772 hasPublicationYear "2011" @default.
- W2010456772 type Work @default.
- W2010456772 sameAs 2010456772 @default.
- W2010456772 citedByCount "17" @default.
- W2010456772 countsByYear W20104567722013 @default.
- W2010456772 countsByYear W20104567722014 @default.
- W2010456772 countsByYear W20104567722015 @default.
- W2010456772 countsByYear W20104567722016 @default.
- W2010456772 countsByYear W20104567722017 @default.
- W2010456772 countsByYear W20104567722018 @default.
- W2010456772 countsByYear W20104567722019 @default.
- W2010456772 countsByYear W20104567722020 @default.
- W2010456772 countsByYear W20104567722021 @default.
- W2010456772 crossrefType "journal-article" @default.
- W2010456772 hasAuthorship W2010456772A5010511809 @default.
- W2010456772 hasAuthorship W2010456772A5025007699 @default.
- W2010456772 hasAuthorship W2010456772A5044672309 @default.
- W2010456772 hasAuthorship W2010456772A5065539463 @default.
- W2010456772 hasConcept C118487528 @default.
- W2010456772 hasConcept C141071460 @default.
- W2010456772 hasConcept C2776403814 @default.
- W2010456772 hasConcept C2776694085 @default.
- W2010456772 hasConcept C2777802072 @default.
- W2010456772 hasConcept C2778257484 @default.
- W2010456772 hasConcept C2780248432 @default.
- W2010456772 hasConcept C2781100027 @default.
- W2010456772 hasConcept C71924100 @default.
- W2010456772 hasConceptScore W2010456772C118487528 @default.
- W2010456772 hasConceptScore W2010456772C141071460 @default.
- W2010456772 hasConceptScore W2010456772C2776403814 @default.
- W2010456772 hasConceptScore W2010456772C2776694085 @default.
- W2010456772 hasConceptScore W2010456772C2777802072 @default.
- W2010456772 hasConceptScore W2010456772C2778257484 @default.
- W2010456772 hasConceptScore W2010456772C2780248432 @default.
- W2010456772 hasConceptScore W2010456772C2781100027 @default.
- W2010456772 hasConceptScore W2010456772C71924100 @default.
- W2010456772 hasIssue "2" @default.
- W2010456772 hasLocation W20104567721 @default.
- W2010456772 hasLocation W20104567722 @default.
- W2010456772 hasOpenAccess W2010456772 @default.
- W2010456772 hasPrimaryLocation W20104567721 @default.
- W2010456772 hasRelatedWork W1507570872 @default.
- W2010456772 hasRelatedWork W1663750035 @default.
- W2010456772 hasRelatedWork W2014260690 @default.
- W2010456772 hasRelatedWork W2024548441 @default.
- W2010456772 hasRelatedWork W2052958850 @default.
- W2010456772 hasRelatedWork W2079794035 @default.
- W2010456772 hasRelatedWork W2124415048 @default.
- W2010456772 hasRelatedWork W2343066505 @default.
- W2010456772 hasRelatedWork W2898797637 @default.
- W2010456772 hasRelatedWork W2085743381 @default.
- W2010456772 hasVolume "46" @default.
- W2010456772 isParatext "false" @default.
- W2010456772 isRetracted "false" @default.
- W2010456772 magId "2010456772" @default.
- W2010456772 workType "article" @default.